In conclusion, one has to say that the literature on CDH1 gene methylation in human breast cancer is contaminated by numerous false-positive results due to the use of non-quantitative methods in a non-cell type-specific manner resulting in the overestimation of spurious methylation signals (in part coming from non-cancer cells). This evidence concerns the gene CDH1 and breast cancer.